Literature DB >> 3355256

Alterations in carbohydrate composition of serum IgG from patients with rheumatoid arthritis and from pregnant women.

J M Pekelharing1, E Hepp, J P Kamerling, G J Gerwig, B Leijnse.   

Abstract

The carbohydrate composition of IgG purified from serum of patients with rheumatoid arthritis (RA), pregnant women, and blood donors has been determined by gas-liquid chromatography. Comparison of the results indicates that IgG from patients with RA contains significantly less galactose but more N-acetylglucosamine than normal IgG, whereas the fucose and sialic acid contents are not changed. The carbohydrate content of IgG in RA is reduced. IgG in pregnancy contains more galactose and more sialic acid than normal IgG, whereas fucose, N-acetylglucosamine, and the total carbohydrate content are not changed. These data suggest a temporal compensation of the RA associated undergalactosylation of IgG in female patients with RA during pregnancy, a period during which remission of the disease is often observed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3355256      PMCID: PMC1003459          DOI: 10.1136/ard.47.2.91

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  24 in total

1.  Oral contraceptives and rheumatoid arthritis: further evidence for a preventive effect.

Authors:  J P Vandenbroucke; H A Valkenburg; J W Boersma; A Cats; J J Festen; O Huber-Bruning; J J Rasker
Journal:  Lancet       Date:  1982-10-16       Impact factor: 79.321

2.  Effect of pregnancy on immune complexes and rheumatoid factors in patients with rheumatoid arthritis.

Authors:  R M Pope; S Yoshinoya; J Rutstein; R H Persellin
Journal:  Am J Med       Date:  1983-06       Impact factor: 4.965

3.  Effect of pregnancy and hormonal changes on the activity of rheumatoid arthritis.

Authors:  M Ostensen; B Aune; G Husby
Journal:  Scand J Rheumatol       Date:  1983       Impact factor: 3.641

4.  The antigenicity of asialylated IgG: its relationship to rheumatoid factor.

Authors:  M D Dodon; G A Quash
Journal:  Immunology       Date:  1981-03       Impact factor: 7.397

Review 5.  Low adrenal androgenic-anabolic steroids in women with rheumatoid arthritis (RA): gas-liquid chromatographic studies of RA patients and matched normal control women indicating decreased 11-deoxy-17-ketosteroid excretion.

Authors:  A T Masi; D B Josipović; W E Jefferson
Journal:  Semin Arthritis Rheum       Date:  1984-08       Impact factor: 5.532

6.  The successful use of asialylated IgG as an immunogen and arthritogen in the rabbit.

Authors:  G Galloway; A Y Leung; I M Hunneyball; D R Stanworth
Journal:  Immunology       Date:  1983-07       Impact factor: 7.397

7.  Regulation of dolichyl phosphate-mediated protein glycosylation: estrogen effects on glucosyl transfers in oviduct membranes.

Authors:  C M Starr; J J Lucas
Journal:  Arch Biochem Biophys       Date:  1985-02-15       Impact factor: 4.013

8.  Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG.

Authors:  R B Parekh; R A Dwek; B J Sutton; D L Fernandes; A Leung; D Stanworth; T W Rademacher; T Mizuochi; T Taniguchi; K Matsuta
Journal:  Nature       Date:  1985 Aug 1-7       Impact factor: 49.962

9.  Variations in the relative proportions of microheterogeneous forms of plasma glycoproteins in pregnancy and disease.

Authors:  J Raynes
Journal:  Biomed Pharmacother       Date:  1982-03       Impact factor: 6.529

10.  Viral neuraminidase and cellular ectosialyltransferase in human lymphoblastoid cells infected with influenza virus.

Authors:  M Duc Dodon; R Cecchelli; R Cacan; L Gazzolo; A Verbert
Journal:  Biochimie       Date:  1984-06       Impact factor: 4.079

View more
  13 in total

Review 1.  Pregnancy and its effect on the risk of developing rheumatoid arthritis.

Authors:  J M Hazes
Journal:  Ann Rheum Dis       Date:  1991-02       Impact factor: 19.103

Review 2.  The role of IgG glycoforms in the pathogenesis of rheumatoid arthritis.

Authors:  T W Rademacher; R B Parekh; R A Dwek; D Isenberg; G Rook; J S Axford; I Roitt
Journal:  Springer Semin Immunopathol       Date:  1988

3.  A possible immunochemical explanation for pregnancy associated remissions in rheumatoid arthritis?

Authors:  D R Stanworth
Journal:  Ann Rheum Dis       Date:  1988-02       Impact factor: 19.103

4.  The history of IgG glycosylation and where we are now.

Authors:  Brian A Cobb
Journal:  Glycobiology       Date:  2020-03-20       Impact factor: 4.313

5.  Lectin analysis of human immunoglobulin G N-glycan sialylation.

Authors:  M Dalziel; I McFarlane; J S Axford
Journal:  Glycoconj J       Date:  1999-12       Impact factor: 2.916

6.  Fc-glycosylation of IgG1 is modulated by B-cell stimuli.

Authors:  Jun Wang; Crina I A Balog; Kathrin Stavenhagen; Carolien A M Koeleman; Hans Ulrich Scherer; Maurice H J Selman; André M Deelder; Tom W J Huizinga; René E M Toes; Manfred Wuhrer
Journal:  Mol Cell Proteomics       Date:  2011-03-03       Impact factor: 5.911

7.  Influence of growth conditions and developmental stage on N-glycan heterogeneity of transgenic immunoglobulin G and endogenous proteins in tobacco leaves.

Authors:  I J Elbers; G M Stoopen; H Bakker; L H Stevens; M Bardor; J W Molthoff; W J Jordi; D Bosch; A Lommen
Journal:  Plant Physiol       Date:  2001-07       Impact factor: 8.340

Review 8.  The role of pregnancy in the course and aetiology of rheumatoid arthritis.

Authors:  J A Da Silva; T D Spector
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

9.  Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients.

Authors:  A Youings; S C Chang; R A Dwek; I G Scragg
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

10.  Changes in normal glycosylation mechanisms in autoimmune rheumatic disease.

Authors:  J S Axford; N Sumar; A Alavi; D A Isenberg; A Young; K B Bodman; I M Roitt
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.